自身免疫性肾病中的第二波抗体：狼疮性肾炎的案例。
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis.
机构信息
Department of Integrated Pediatric and Hemato-Oncology Sciences, Laboratory of Molecular Nephrology, Scientific Institute for Research and Health Care, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Giannina Gaslini, Genoa, Italy.
Division of Nephrology, Dialysis and Transplantation, Scientific Institute for Research and Health Care, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Giannina Gaslini, Genoa, Italy.
出版信息
J Am Soc Nephrol. 2021 Dec 1;32(12):3020-3023. doi: 10.1681/ASN.2021050659.
Abstract
Clinical Trial registry name and registration number: Zeus study, NCT02403115.
摘要
临床试验注册名称和注册号
宙斯研究，NCT02403115。
相似文献
1
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis.自身免疫性肾病中的第二波抗体：狼疮性肾炎的案例。
J Am Soc Nephrol. 2021 Dec 1;32(12):3020-3023. doi: 10.1681/ASN.2021050659.
2
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.血清 IgG2 抗体在系统性红斑狼疮和狼疮肾炎中的多成分分析（第 2 部分）：前瞻性研究。
Rheumatology (Oxford). 2021 Jul 1;60(7):3388-3397. doi: 10.1093/rheumatology/keaa793.
3
Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis.狼疮性肾炎患者的抗磷脂抗体与肾脏结局
Intern Med. 2009;48(21):1875-80. doi: 10.2169/internalmedicine.48.2363. Epub 2009 Nov 2.
4
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.血清 IgG2 抗体在系统性红斑狼疮和狼疮肾炎中的多组份表现（第 1 部分）：横断面分析。
Rheumatology (Oxford). 2021 Jul 1;60(7):3176-3188. doi: 10.1093/rheumatology/keaa767.
5
Comparative analysis of SGLT-2 expression in renal vasculitis and lupus nephritis.肾血管炎和狼疮性肾炎中SGLT-2表达的比较分析。
Ann Rheum Dis. 2022 Jul;81(7):1048-1050. doi: 10.1136/annrheumdis-2022-222167. Epub 2022 Feb 25.
6
Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.系统性红斑狼疮患者中组织学抗磷脂抗体相关肾病与狼疮性肾炎的比较：一项纵向随访的观察性横断面研究
Arthritis Res Ther. 2015 Apr 27;17(1):109. doi: 10.1186/s13075-015-0614-5.
7
Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis.初发系统性红斑狼疮和狼疮性肾炎患者的中性粒细胞胞外诱捕网特征
J Rheumatol. 2020 Mar;47(3):377-386. doi: 10.3899/jrheum.181232. Epub 2019 May 15.
8
Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.白细胞介素-35作为狼疮性肾炎患者肾脏受累的新型生物标志物
Tohoku J Exp Med. 2018 Apr;244(4):263-270. doi: 10.1620/tjem.244.263.
9
[Renal changes in systemic lupus erythematosus (lupus nephritis)].[系统性红斑狼疮的肾脏改变（狼疮性肾炎）]
Pol Tyg Lek. 1961 Nov 27;16:1853-7.
10
Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.抗五聚体蛋白3自身抗体可能对狼疮性肾炎具有保护作用：一项大型队列研究。
Ren Fail. 2017 Nov;39(1):465-473. doi: 10.1080/0886022X.2017.1308258.
引用本文的文献
1
Serum glutathione reductase level as a disease activity biomarker in systemic lupus erythematosus: a single-centre preliminary study.血清谷胱甘肽还原酶水平作为系统性红斑狼疮疾病活动生物标志物的单中心初步研究。
Lupus Sci Med. 2025 Jun 24;12(1):e001593. doi: 10.1136/lupus-2025-001593.
2
Antibodies Against Anti-Oxidant Enzymes in Autoimmune Glomerulonephritis and in Antibody-Mediated Graft Rejection.自身免疫性肾小球肾炎及抗体介导的移植排斥反应中针对抗氧化酶的抗体
Antioxidants (Basel). 2024 Dec 12;13(12):1519. doi: 10.3390/antiox13121519.
3
Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond.膜性肾病的新型生物标志物与病理生理学：磷脂酶A2受体及其他
Clin Kidney J. 2023 Dec 11;17(1):sfad228. doi: 10.1093/ckj/sfad228. eCollection 2024 Jan.
4
Combination of rituximab and short-term glucocorticoids in the treatment of anti-phospholipase A receptor antibody positive idiopathic membranous nephropathy.利妥昔单抗联合短期糖皮质激素治疗抗磷脂酶 A2 受体抗体阳性特发性膜性肾病。
Clin Exp Med. 2023 Dec;23(8):5337-5343. doi: 10.1007/s10238-023-01183-1. Epub 2023 Sep 9.
5
Mechanisms Limiting Renal Tissue Protection and Repair in Glomerulonephritis.肾小球肾炎中限制肾脏组织保护和修复的机制。
Int J Mol Sci. 2023 May 5;24(9):8318. doi: 10.3390/ijms24098318.
6
An update on autoantibodies in systemic lupus erythematosus.系统性红斑狼疮中自身抗体的最新研究进展。
Curr Opin Rheumatol. 2023 Mar 1;35(2):61-67. doi: 10.1097/BOR.0000000000000922. Epub 2022 Dec 22.
7
Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy.静脉注射环磷酰胺作为口服环磷酰胺改良Ponticelli方案的替代方案用于高危PLA2R阳性膜性肾病。
J Nephrol. 2023 Mar;36(2):293-295. doi: 10.1007/s40620-022-01426-6. Epub 2022 Aug 12.
8
Discovery of anti-Formin-like 1 protein (FMNL1) antibodies in membranous nephropathy and other glomerular diseases.在膜性肾病和其他肾小球疾病中发现抗formin-like 1 蛋白（FMNL1）抗体。
Sci Rep. 2022 Aug 11;12(1):13659. doi: 10.1038/s41598-022-17696-w.
Zotero 插件